![](/img/cover-not-exists.png)
Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus (T2DM)
Philippe Brudi, Helena Vaverkova, Michel Farnier, Maurizio Averna, Margus Viigimaa, Qian Dong, Arvind Shah, Amy O. Johnson-Levonas, Luc MissaultVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/j.jacl.2009.04.042
File:
PDF, 96 KB
english, 2009